(Q44857263)

6 December 2017

Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide (English)

1 reference

6 December 2017

retinal vein occlusion

1 reference

Jonas JB

1

1 reference

6 December 2017

Akkoyun I

2

1 reference

6 December 2017

Kamppeter B

3

1 reference

6 December 2017

Kreissig I

4

1 reference

6 December 2017

Degenring RF

5

1 reference

6 December 2017

1 January 2005

1 reference

6 December 2017

1 reference

6 December 2017

19

1 reference

6 December 2017

1

1 reference

6 December 2017

65-71

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.eye.6701395

6 December 2017

0 references

cites work

Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal triamcinolone for refractory diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal triamcinolone for refractory pseudophakic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Exudative macular degeneration and intravitreal triamcinolone. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

ICGA-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Indocyanine green angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal triamcinolone acetonide for exudative age related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal triamcinolone for treatment of chronic focal immunological corneal graft reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Neovascular glaucoma treated by intravitreal triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Concentration of intravitreally injected triamcinolone acetonide in aqueous humour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intraocular pressure after intravitreal injection of triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Evaluation of the Retinal Toxicity and Pharmacokinetics of Dexamethasone After Intravitreal Injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

7 January 2021

Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

7 January 2021

Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

7 January 2021

Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

7 January 2021

Cataract surgery after intravitreal injection of triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

7 January 2021

Intravitreal triamcinolone acetonide as treatment for extensive exudative retinal detachment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

7 January 2021

Intraocular availability of triamcinolone acetonide after intravitreal injection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

7 January 2021

Intravitreal triamcinolone and elevated intraocular pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

7 January 2021

Nontuberculous mycobacterial endophthalmitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

7 January 2021

Morphallaxia-like ocular histology after intravitreal triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

7 January 2021

The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

7 January 2021

The lack of toxicity of intravitreally administered triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

7 January 2021

Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701395

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6701395

1 reference

6 December 2017

1 reference